Lobbyists Resetting Trump Expectations
By Megan R. Wilson
“We’ve pivoted from a reform agenda to a reauthorization agenda,” said Jenn Higgins, a partner at Chamber Hill Strategies, who specializes in healthcare policy. “We thought this was going to be the year that big things would get done.”
The focus is now reauthorizing big, established healthcare programs, such as the Children’s Health Insurance Program and the Prescription Drug User Fee Act, Higgins said.
“If there are opportunities for policy developments, you’re going to have to play on the edges of those issues,” she said, adding that the Department of Health and Human Services, run by former Rep. Tom Price (R-Ga.), is already having listening sessions with lobbyists and stakeholders.
“If AHCA is not the policy goal, our focus and our energy will be on regulatory and administrative policy development,” Higgins said, referring to the GOP’s healthcare bill, the American Health Care Act.